# Almac

an API chemical-development CDMO running immobilised-lipase (CALB) biocatalysis and cGMP flow-hydrogenation capability for late-stage sponsor process development.

Source: https://en.bioecon.ru/companies/almac/
Updated: 2026-07-20

- Country: United Kingdom

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | £1.1 billion | https://pomanda.com/company/NI041551/almac-group-limited, https://www.almacgroup.com/news/almac-group-delivers-record-year-of-growth/ |
| Headcount | more than 7,900 employees | https://www.almacgroup.com/news/almac-group-delivers-record-year-of-growth/ |
| Headquarters | Craigavon, Northern Ireland | https://www.almacgroup.com/wp-content/uploads/2025/12/Corporate-Brochure-December-2025.pdf, https://www3.almacgroup.com/hubfs/Almac-Overview-Media-and-Press-Release-Kit.pdf |
| Regulatory approval | cGMP compliant flow hydrogenation capability | https://pharmasource.global/content/news/cdmo-news/almac-sciences-expands-api-services-with-cgmp-flow-hydrogenation-technology/, https://www.almacgroup.com/news/almac-sciences-launches-new-cgmp-flow-hydrogenation-capability/ |
| Production site | 18 facilities in Europe, North America, and Asia | https://www.almacgroup.com/wp-content/uploads/2025/12/Corporate-Brochure-December-2025.pdf |

Independent sources: pharmasource.global, pomanda.com

## Technologies

- [Chemoenzymatic API synthesis (biocatalytic small-molecule manufacturing)](https://en.bioecon.ru/technology/chemoenzymatic-api-synthesis/)